NCT02581930 2026-04-30Ibrutinib in Treating Patients With Refractory Metastatic Cutaneous MelanomaNational Cancer Institute (NCI)Phase 2 Active not recruiting18 enrolled 10 charts
NCT00036764 2013-01-25BMS-247550 in Treating Patients With Stage IV MelanomaNational Cancer Institute (NCI)Phase 2 Completed88 enrolled